Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | N/A | 0 | 437 |
| TOTAL | $0 | $0 | $N/A | $0 | $437 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 599 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $599 |
| Total Assets | $0 | $0 | $N/A | $0 | $1,036 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | N/A | 0 | 4 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 1,629 |
| TOTAL | $0 | $0 | $N/A | $0 | $1,633 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 582 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $582 |
| Total Liabilities | $0 | $0 | $N/A | $0 | $2,215 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | N/A | 0 | 10 |
| Retained earnings | 0 | 0 | N/A | 0 | -4,400 |
| TOTAL | $0 | $0 | $N/A | $0 | $-1,179 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $1,036 |